A complete guide to taking and purchasing Lucius version of capmatinib generic drugs

The generic drug of capmatinib launched by Lucius is an effective targeted therapy for MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC), broadening treatment pathways for many patients. This article will explain in detail the correct method of taking this drug and the purchasing guide to help patients master and use this drug more accurately.

1. Instructions for use

The Lucius version of the generic drug of capmatinib is taken in a manner similar to the original drug, but patients still need to strictly follow the doctor's instructions. The recommended dosage is 400 mg taken orally twice daily (i.e. two 200 mg tablets), with or without food. The key is that the tablets must be swallowed whole and not crushed, cut or chewed to ensure complete release and optimal absorption of the drug.

If a patient occasionally misses a dose or vomits after taking a dose, it is usually not recommended to take a missed dose, but should continue to take the next dose as originally planned. For patients who cannot tolerate the twice daily dose, they should communicate with their doctor in time to adjust the medication regimen.

During the medication period, patients should pay close attention to their own reactions, especially common side effects such as peripheral edema, nausea, fatigue, vomiting, dyspnea and loss of appetite. If you experience serious side effects, such as interstitial lung disease (ILD)/pneumonitis or liver damage, you should stop taking the drug immediately and seek medical help.

2. Buying Guide

When purchasing the Lucius version of capmatinib generics, patients must carefully choose reliable and formal channels, such as purchasing through the assistance of a professional medical team or the help of overseas relatives and friends. At the same time, be sure to verify the source and authenticity of the medication to ensure its safety.

In terms of price, the Lucius version of the generic drug of capmatinib is more economical and affordable than the original drug. The price of a box is about 3,000 yuan. However, it should be noted that the price may fluctuate due to factors such as exchange rate and market supply and demand. The specific price is subject to the real-time selling price of the pharmaceutical factory.

In summary, the Lucius version of the generic version of capmatinib provides new treatment opportunities for NSCLC patients carryingMET exon 14 skipping mutations. When using it, patients should strictly follow the doctor's instructions and pay attention to the details of medication and monitoring of side effects. At the same time, when purchasing drugs, you should also choose reliable channels to ensure the safety and effectiveness of the drugs.